多重の基板受容体相互作用が,フローの下での血小板血栓形成における特異的な相乗効果である
B Savage1, F Almus-Jacobs, Z M Ruggeri
1The Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Cell
|September 19, 1998
まとめ
血小板の粘着と血栓形成は,コラーゲンのような表面との特定の相互作用に依存しています. 血動力学力と表面のタイプによって,どの粘着経路が活性化され,血栓形成に影響を及ぼすかを決定します.
科学分野:
- 血液学 ヘマトロジ
- バイオフィジックス 生物物理学
- 細胞生物学 細胞生物学
背景:
- 血小板の粘着は,血静と血栓形成に不可欠です.
- 血小板表面相互作用の分子機構を理解することは,血栓性疾患の治療に不可欠です.
研究 の 目的:
- 血小板血栓形成中のリアルタイムの粘着相互作用を生物学的に関連する表面で調査する.
- 血小板粘着経路における特定の分子と血動力学的力の役割を明らかにする.
主な方法:
- リアルタイムのコンフォカルビデオ顕微鏡.
- 血小板相互作用の観察 I型コラーゲン線維と血液流動の条件下におけるサブエンドセリアマトリックス.
主要な成果:
- 血小板がグリコプロテインIbアルファを介してフォン・ウィレブランド因子 (vWF) に結合することは,高い切断率で不可欠です.
- インテグリンアルファ2ベータ1とアルファ(IIb) ベータ3は,不可逆的な粘着と血栓の成長を媒介する.
- 内生性および吸収性VWFの両方が,サブエンドセリアマトリックスにおける血小板の徴集に寄与する.
- Alpha2beta1とalpha(IIb) beta3は,低シア率を除いて,シア率を超えて血栓発症に不可欠です.
結論:
- 血液動力学力と基質特性は,血小板の固着経路を決定し,血栓形成に関与する.
- vWF,血小板受容体,およびシアストレスの間の相互作用は,血栓形成を調節する.
関連する概念動画
01:17Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
01:22Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.1K
01:16Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K